Crohn’s disease associated with adverse outcomes in patients undergoing THA
Click Here to Manage Email Alerts
Patients with Crohn’s disease who undergo total hip arthroplasty may be at higher risk of medical complications, longer hospital stays and increased costs of care, according to published results.
To assess the impact of Crohn’s disease on THA outcomes, Lucas C. Voyvodic, BS, and colleagues analyzed a cohort of 9,229 patients with Crohn’s disease who underwent primary THA from Jan. 1, 2005 to March 31, 2014. Researchers matched the study group with a control cohort of 46,132 patients who underwent the same procedure with similar age, sex and comorbidities.
According to the study, primary outcome measures included in-hospital length of stay (LOS), 90-day complication rate and cost of care (day of surgery and 90-day episode costs).
Voyvodic and colleagues found patients with Crohn’s disease had a “significantly higher” incidence of 90-day medical complications (30.2 for the study group vs. 13.8 for the control group). Additionally, researchers found patients with Crohn’s disease had a longer mean in-hospital LOS (3.8 days for the study group vs. 3.6 days for the control group) and higher costs of care on the day of surgery ($12,662.00, study group vs. $12,271.15, control group) and 90-day episode costs ($16,933.18 for the study group vs. $15,670.32 for the control group).
Researchers concluded that patients with Crohn’s disease are at higher risk for poor outcomes after THA.
“It is important for patients to be aware of the increased risks of complications associated with their condition following primary THA as well as subsequent increases in costs,” Voyvodic and colleagues wrote in the study. “This study will assist physicians in planning pre- and postoperative management of these unique patients to avoid potential complications and give physicians necessary information to perform appropriate risk adjustment for these patients.”
Collapse
Read more about
Click Here to Manage Email Alerts